Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-10 Sale |
2025-02-12 5:13 pm |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
4,618 | $15.5 | $71,597 | 85,095 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:45 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
41,900 | $0 | 200,213 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:45 pm |
N/A 2035-02-05 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
110,500 | $14.65 | 200,213 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:49 pm |
N/A 2034-12-09 |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-04-02 Option Award |
2024-04-02 9:54 pm |
N/A 2034-04-01 |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
74,000 | $0 | 74,000 (Direct) |
View |
Ownership |
2024-04-02 9:52 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Gallagher Neil Director |
0 | $0 | 0 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
47,813 | $0 | 117,188 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A 2034-02-07 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
69,375 | $22.28 | 117,188 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-12 4:02 pm |
N/A 2033-04-10 |
Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D |
250,000 | $19.35 | 250,000 (Direct) |
View |